Literature DB >> 27720686

Role of pannexin 1 in Clostridium perfringens beta-toxin-caused cell death.

Soshi Seike1, Masaya Takehara1, Keiko Kobayashi1, Masahiro Nagahama2.   

Abstract

BACKGROUND: Beta-toxin produced by Clostridium perfringens is a key virulence factor of fatal hemorrhagic enterocolitis and enterotoxemia. This toxin belongs to a family of β-pore-forming toxins (PFTs). We reported recently that the ATP-gated P2X7 receptor interacts with beta-toxin. The ATP-release channel pannexin 1 (Panx1) is an important contributor to P2X7 receptor signaling. Hence, we investigated the involvement of Panx1 in beta-toxin-caused cell death.
METHODS: We examined the effect of Panx1 in beta-toxin-induced cell death utilizing selective antagonists, knockdown of Panx1, and binding using dot-blot analysis. Localization of Panx1 and the P2X7 receptor after toxin treatment was determined by immunofluorescence staining.
RESULTS: Selective Panx1 antagonists (carbenoxolone [CBX], probenecid, and Panx1 inhibitory peptide) prevented beta-toxin-caused cell death in THP-1 cells. CBX did not block the binding of the toxin to cells. Small interfering knockdown of Panx1 blocked beta-toxin-mediated cell death through inhibiting the oligomer formation of the toxin. Beta-toxin triggered a transient ATP release from THP-1 cells, but this early ATP release was blocked by CBX. ATP scavengers (apyrase and hexokinase) inhibited beta-toxin-induced cytotoxicity. Furthermore, co-administration of ATP with beta-toxin enhanced the binding and cytotoxicity of the toxin.
CONCLUSIONS: Based on our results, Panx1 activation is achieved through the interaction of beta-toxin with the P2X7 receptor. Then, ATP released by the Panx1 channel opening promotes oligomer formation of the toxin, leading to cell death. GENERAL SIGNIFICANCE: Pannexin 1 is a novel candidate therapeutic target for beta-toxin-mediated disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C. perfringens beta-toxin; Oligomer formation; Pannexin 1; Pore-forming toxin

Mesh:

Substances:

Year:  2016        PMID: 27720686     DOI: 10.1016/j.bbamem.2016.10.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

Review 2.  Mechanisms of Action and Cell Death Associated with Clostridium perfringens Toxins.

Authors:  Mauricio A Navarro; Bruce A McClane; Francisco A Uzal
Journal:  Toxins (Basel)       Date:  2018-05-22       Impact factor: 4.546

3.  Effect of Clostridium perfringens β-Toxin on Platelets.

Authors:  Anne Thiel; Helga Mogel; Julia Bruggisser; Arnaud Baumann; Marianne Wyder; Michael H Stoffel; Artur Summerfield; Horst Posthaus
Journal:  Toxins (Basel)       Date:  2017-10-24       Impact factor: 4.546

Review 4.  The two faces of pannexins: new roles in inflammation and repair.

Authors:  Helen P Makarenkova; Sameer B Shah; Valery I Shestopalov
Journal:  J Inflamm Res       Date:  2018-06-21

5.  Clostridium perfringens α-toxin impairs granulocyte colony-stimulating factor receptor-mediated granulocyte production while triggering septic shock.

Authors:  Masaya Takehara; Soshi Seike; Yuuta Sonobe; Hiroto Bandou; Saki Yokoyama; Teruhisa Takagishi; Kazuaki Miyamoto; Keiko Kobayashi; Masahiro Nagahama
Journal:  Commun Biol       Date:  2019-01-31

6.  An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity.

Authors:  Guojie Ding; Jing Bai; Baohua Feng; Li Wang; Xinyuan Qiao; Han Zhou; Yanping Jiang; Wen Cui; Lijie Tang; Yijing Li; Yigang Xu
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

7.  Pathogenicity and virulence of Clostridium perfringens.

Authors:  Iman Mehdizadeh Gohari; Mauricio A Navarro; Jihong Li; Archana Shrestha; Francisco Uzal; Bruce A McClane
Journal:  Virulence       Date:  2021-12       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.